BUSINESS WIRE: Investigational BRINAVESS® (vernakalant) for Infusion Recommended for Approval by the CHMP in the …

BUSINESS WIRE: Investigational BRINAVESS® (vernakalant) for Infusion Recommended for Approval by the CHMP in the …
MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH. Merck (known as MSD outside the United States and Canada) (NYSE:MRK) and Cardiome Pharma Corp. (NASDAQ: CRME/ TSX: COM) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended marketing approval for …